欢迎来到联参智库! | 帮助中心 联合作战情报参考网
联参智库

生物制品

https:crsreports.congress.gov Updated September 29, 2021Medical Product Regulation: Drugs, Biologics, and DevicesThe Fo, FollowOn Biologics: Intellec

生物制品Tag内容描述:

1、 https:crsreports.congress.gov Updated September 29, 2021Medical Product Regulation: Drugs, Biologics, and DevicesThe Fo。

2、 FollowOn Biologics: Intellectual Property Issues name redacted Visiting Scholar August 28, 2015 Congressional Research 。

3、CRS Report for CongressPrepared for Members and Committees of Congress FollowOn Biologics: The Law and Intellectual Prop。

4、CRS Report for CongressPrepared for Members and Committees of Congress FDA User Fees and the Regulation of Drugs, Biolog。

5、CRS Report for CongressPrepared for Members and Committees of Congress FDA Regulation of FollowOn Biologics name redacte。

6、CRS Report for CongressPrepared for Members and Committees of Congress FollowOn Biologics: Intellectual Property and Inn。

【生物制品】相关PDF文档
[20210929]IF11083_医疗产品法规:药物、生物制品和设备.pdf
[20150828]R44173_后续生物制品:知识产权问题.pdf
[20140115]R41483_后续生物制品:法律和知识产权问题.pdf
[20100426]RL34045_FDA对后续生物制品的监管.pdf
[20100106]RL33901_后续生物制品:知识产权和创新问题.pdf
1

客服:010-66465788   北京联参科技有限公司版权所有  工业和信息化部备案/许可证编号:京ICP备2022007273号-1



联参智库